Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -430 | -1,060 | -798 | -471 | 2 |
| Depreciation Amortization | 18 | 134 | 75 | 48 | 4 |
| Accounts receivable | 3 | -151 | -82 | -222 | N/A |
| Other Working Capital | -107 | -2 | 138 | -78 | -110 |
| Other Operating Activity | 63 | 654 | 223 | 315 | 105 |
| Operating Cash Flow | $-453 | $-424 | $-444 | $-407 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-14 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,000 | N/A | 54 | 118 | N/A |
| Debt Repayment | -86 | 31 | 26 | 45 | N/A |
| Other Financing Activity | 0 | 365 | 336 | 216 | 0 |
| Financing Cash Flow | $914 | $396 | $416 | $379 | $N/A |
| Beginning Cash Position | N/A | 28 | 28 | 28 | N/A |
| End Cash Position | 447 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $447 | $-28 | $-28 | $-28 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -453 | -424 | -444 | -407 | N/A |
| Capital Expenditure | -14 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -467 | -424 | -444 | -407 | 0 |